Literature DB >> 32513764

Todd's paresis following vasovagal syncope provoked by tilt-table testing.

David Moloney1,2, Laura Perez Pérez-Denia3,4, Rose Anne Kenny3,4.   

Abstract

A 38-year-old woman presented with a history of recurrent episodes of transient loss of consciousness (TLOC) with seizure-like activity and post-TLOC left sided paresis. Electroencephalogram and MRI of the brain were normal, and events were not controlled by anti-convulsant therapy. Tilt testing produced reflex mixed pattern vasovagal syncope, with exact symptom reproduction, including bilateral upper and lower limb myoclonic movements and post-TLOC left hemiparesis that persisted for 27 min. A witness for the tilt event confirmed reproduction of patients 'typical' TLOC event. Syncope is the most frequent cause of TLOC. Myoclonic movements during syncope are not uncommon and can be misdiagnosed as epilepsy. It is rare to experience paresis after syncope, which in this case, lead to misdiagnosis and unnecessary anti-convulsant treatment. © BMJ Publishing Group Limited 2020. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  cardiovascular medicine; epilepsy and seizures

Mesh:

Year:  2020        PMID: 32513764      PMCID: PMC7282304          DOI: 10.1136/bcr-2020-234402

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  10 in total

1.  Syncope and cerebral hypoperfusion.

Authors:  Shelagh B Coutts; William Hu; Michael D Hill
Journal:  Neurology       Date:  2003-06-24       Impact factor: 9.910

2.  Syncope causes transient focal neurological symptoms.

Authors:  D J Ryan; J A Harbison; J F Meaney; C P Rice; B King-Kallimanis; R A Kenny
Journal:  QJM       Date:  2015-01-27

3.  Effectiveness of physical counterpressure maneuvers in preventing vasovagal syncope: the Physical Counterpressure Manoeuvres Trial (PC-Trial).

Authors:  Nynke van Dijk; Fabio Quartieri; Jean-Jaques Blanc; Roberto Garcia-Civera; Michele Brignole; Angel Moya; Wouter Wieling
Journal:  J Am Coll Cardiol       Date:  2006-09-26       Impact factor: 24.094

4.  2018 ESC Guidelines for the diagnosis and management of syncope.

Authors:  Michele Brignole; Angel Moya; Frederik J de Lange; Jean-Claude Deharo; Perry M Elliott; Alessandra Fanciulli; Artur Fedorowski; Raffaello Furlan; Rose Anne Kenny; Alfonso Martín; Vincent Probst; Matthew J Reed; Ciara P Rice; Richard Sutton; Andrea Ungar; J Gert van Dijk
Journal:  Eur Heart J       Date:  2018-06-01       Impact factor: 29.983

5.  Amnesia for loss of consciousness is common in vasovagal syncope.

Authors:  Clodagh O'Dwyer; Kathleen Bennett; Yvonne Langan; Chie Wei Fan; Rose Anne Kenny
Journal:  Europace       Date:  2011-03-23       Impact factor: 5.214

6.  Differentiating motor phenomena in tilt-induced syncope and convulsive seizures.

Authors:  Sharon Shmuely; Prisca R Bauer; Erik W van Zwet; J Gert van Dijk; Roland D Thijs
Journal:  Neurology       Date:  2018-03-16       Impact factor: 9.910

Review 7.  The management of vasovagal syncope.

Authors:  R A Kenny; T McNicholas
Journal:  QJM       Date:  2016-06-23

8.  Clinical spectrum and prevalence of neurologic events provoked by tilt table testing.

Authors:  Rod Passman; George Horvath; Jay Thomas; Jane Kruse; Anand Shah; Jeffrey Goldberger; Alan Kadish
Journal:  Arch Intern Med       Date:  2003-09-08

9.  The semiology of tilt-induced reflex syncope in relation to electroencephalographic changes.

Authors:  J Gert van Dijk; Roland D Thijs; Erik van Zwet; Martijn R Tannemaat; Julius van Niekerk; David G Benditt; Wouter Wieling
Journal:  Brain       Date:  2013-12-16       Impact factor: 13.501

10.  Syncope and Epilepsy coexist in 'possible' and 'drug-resistant' epilepsy (Overlap between Epilepsy and Syncope Study - OESYS).

Authors:  Andrea Ungar; Alice Ceccofiglio; Francesca Pescini; Chiara Mussi; Gianni Tava; Martina Rafanelli; Assunta Langellotto; Niccolò Marchionni; J Gert van Dijk; Gianlugi Galizia; Domenico Bonaduce; Pasquale Abete
Journal:  BMC Neurol       Date:  2017-02-28       Impact factor: 2.474

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.